SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.

Aileen X Wang,Stephan Busque, Jamie Kuo,Upinder Singh,Katharina Röeltgen,Benjamin A Pinsky,Glenn M Chertow,John D Scandling,Colin R Lenihan

Kidney360（2022）

引用 9|浏览9

暂无评分

摘要

Bamlanivimab and casirivimab-imdevimab combined with immunosuppression reduction were well tolerated and associated with favorable clinical outcomes in kidney transplant recipients diagnosed with mild to moderate COVID-19.

查看译文

关键词

COVID-19,SARS-CoV-2,immunosuppression,kidney transplant,monoclonal antibodies,transplantation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要